Benjamin R. Yerxa, President at Opus Genetics, Inc. (IRD), bought 10,000 shares at $0.98 ($10K) on 2024-11-21, disclosed to the SEC on 2024-11-25.
Open-market purchase of $10k IRD by President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CLSD | BUY | 2024-05-15 | $10K | — | Filing → |
| ISPH | SELL | 2010-05-05 | $13K | — | Filing → |
| ISPH | SELL | 2010-04-05 | $13K | — | Filing → |